The results show that osthole may act on MAPK3, MAPK1, AKT1, SRC, and other targets through PI3K/AKT, MAPK, and other signaling pathways, indicating that osthole has the potential to synergistically treat gastric cancer through multiple components, multiple targets, and multiple pathways. Here, MAPK3 is linked to gastric cancer.